Back

Evidence from outcome trials: low-density lipoprotein cholesterol reduction and cardiovascular benefit

29 August 2026 (12:43 - 12:51)
Organised by: Logo
Congress Presentation Part of: Transforming low-density lipoprotein cholesterol care: from correct risk assessment to combination therapies Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Julia Brandts

University Hospital Frankfurt, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor L. Tokgozoglu (Ankara, TR)
Presentation thumbnail
Correct risk, correct treatment: insights from SANTORINI
Professor K. Ray (London, GB)
Presentation thumbnail
From trial evidence to real-world practice: efficacy, safety profiles and risk reduction
Professor J. Jukema (Leiden, NL)
Presentation thumbnail
Oral combination therapy: closing the low-density lipoprotein cholesterol gap
Professor L. Masana (Reus, ES)
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
Transforming low-density lipoprotein cholesterol care: from correct risk assessment to combination therapies

The Event

Event poster

ESC Congress 2026

29 August 2026 12:43 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
11 April 2024
thumbnail
Congress Presentation
Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the criso project.
3 April 2025
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
15 April 2024
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
7 October 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources